Stay updated on REGN5678 Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the REGN5678 Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the REGN5678 Combo in Metastatic Prostate Cancer Clinical Trial page
- ChecktodayChange DetectedA new revision entry v3.6.4 was added to the history, reflecting a site update. The previous revision v3.6.3 was removed from the current listing.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check14 days agoChange DetectedVersion 24 added new sections for Contacts/Locations and Study Status around 2026-07-08/09, reflecting updated contact details and the trial's current status. The 2026-06-25 deletion indicates removal of earlier data from the history.SummaryDifference0.4%

- Check22 days agoChange DetectedAdded a new page revision, v3.6.3, to the study's history to reflect the latest update to the page. The previous revision, v3.6.2, is shown as a deletion in this update.SummaryDifference0.1%

- Check29 days agoChange DetectedThe history now includes the Contacts/Locations and Study Status sections in the latest revision (v3.6.2, dated 2026-06-25). This presents who/where to contact for the trial and the current recruitment status within the record history.SummaryDifference0.5%

- Check43 days agoChange DetectedNew links 'Check who can join' and 'Find Contact Information' were added to the page. The revision label was updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.4%

- Check50 days agoChange DetectedHistory now shows a new revision tag v3.5.5 in place of the previous v3.5.4, indicating a content update to the page. This update pertains to versioning of the page rather than changes to trial data or study details.SummaryDifference0.1%

Stay in the know with updates to REGN5678 Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN5678 Combo in Metastatic Prostate Cancer Clinical Trial page.